SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-16-000107
Filing Date
2016-10-31
Accepted
2016-10-31 16:48:15
Documents
77
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2016q310-q.htm 10-Q 1488879
2 EXHIBIT 10.1 a2016q310-q_exhibit102.htm EX-10.1 1365691
3 EXHIBIT 31.1 a2016q310-q_exhibit311.htm EX-31.1 14551
4 EXHIBIT 31.2 a2016q310-q_exhibit312.htm EX-31.2 14385
5 EXHIBIT 32.1 a2016q310-q_exhibit321.htm EX-32.1 11908
  Complete submission text file 0000875320-16-000107.txt   9541102

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vrtx-20160930.xml EX-101.INS 1996410
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20160930.xsd EX-101.SCH 59157
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20160930_cal.xml EX-101.CAL 92124
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20160930_def.xml EX-101.DEF 292310
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20160930_lab.xml EX-101.LAB 730477
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20160930_pre.xml EX-101.PRE 433595
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 161962174
SIC: 2834 Pharmaceutical Preparations